A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101

Clinical trial NCT04947124 · COMPLETED

Trial details

NCT number: NCT04947124
Sponsor: Qlaris Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sturge-Weber Syndrome (SWS)Glaucoma Glaucoma Congenital Ocular Hypertension

Start date: 2021-10-19
Primary completion: 2022-06-06
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.